Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice

Stephan Blüml1, Michael Bonelli, Birgit Niederreiter

  • 1Medical University of Vienna, Vienna, Austria.

Arthritis and Rheumatism
|February 16, 2011
PubMed
Abstract

Insights

MicroRNA-155 (miR-155) plays a crucial role in autoimmune arthritis development. Its deficiency prevents pathogenic immune cell generation and reduces bone destruction in mouse models, suggesting miR-155 as a potential therapeutic target for rheumatoid arthritis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • MicroRNAs (miRNAs) are key regulatory elements in cellular processes.
  • Dysregulated miRNA expression is observed in rheumatoid arthritis (RA) joint inflammation.
  • The specific role of miRNAs in autoimmune arthritis pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the role of microRNA-155 (miR-155) in the pathogenesis of autoimmune arthritis.
  • To utilize two distinct murine models of arthritis to elucidate miR-155's function.
  • To assess the impact of miR-155 deficiency on adaptive and innate immune responses in arthritis.

Main Methods:

  • Induction of collagen-induced arthritis (CIA) and K/BxN serum-transfer arthritis in wild-type and miR-155-deficient mice.
  • Clinical and histological assessment of arthritis severity.
  • Measurement of anti-collagen antibodies, cytokines (IL-17, IL-22), and cellular composition via ELISA and flow cytometry.

Main Results:

  • miR-155 deficiency completely prevented the development of CIA.
  • Absence of miR-155 reduced pathogenic autoreactive B and T cell generation, including Th17 polarization.
  • In the K/BxN model, miR-155 deficiency decreased osteoclast generation and subsequent bone destruction, while joint inflammation severity remained similar.

Conclusions:

  • miR-155 is integral to both adaptive and innate immune responses driving autoimmune arthritis.
  • Targeting miR-155 presents a potential novel therapeutic strategy for rheumatoid arthritis.
  • These findings highlight miR-155's critical role in immune-mediated joint diseases.